Edward Yeh

Edward T. H. Yeh, M.D., FACC

Full Bio

 

 

 

 

 

 

Hui-Ming Chang

Hui-Ming Chang, M.D., MPH

Professor of Pharmacology, Toxicology and Internal Medicine

About Dr. Hui-Ming Chang

Dr. Hui-Ming Chang joined UAMS on November 1, 2020 as Professor of Pharmacology, Toxicology and Internal Medicine. Dr. Chang is a cross-discipline physician scientist with academic leadership experience in research, administration, education, and clinical medicine. She received her medical degree from National Taiwan University, master of public health in Epidemiology and master of science in Physiology from Harvard Chan School of Public Health.  Her post-graduate trainings include internship at George Washington University Medical Center, residency at Boston University Medical Center, and clinical and research fellowship at Harvard Medical School, Boston Children’s Hospital.  Dr. Chang comes to UAMS from University of Missouri School of Medicine where she was co-director of the Center for Precision Medicine and associate professor.  Prior to U. of Missouri, she was faculty at Harvard Medical School, Massachusetts General Hospital, U. of Texas MD Anderson Cancer Center, and U. of Texas Health Science Center at Houston. Her prior academic positions include vice president for international programs and special advisor to the president at the U. of Texas Health Science Center at Houston, director of senior clinical performance examination at U. of Texas Houston Medical School, and director of education, Department of Palliative Care and Rehabilitation at U. of Texas MD Anderson Cancer Center.

Her services on national and institutional committees include Board of Directors of the American Academy of Pain Medicine, Executive Council of the University of Texas Health Science Center at Houston, and scientific advisory committee of the university clinical research center at the U. of Texas Health Science Center at Houston and M.D. Anderson Cancer Center. She was the recipient of Fleming and Davenport award and medical honoree of American Heart Association Houston Heart Ball.

Her contributions to medical sciences include opioid effects on evoked substance P release from primary sensory neurons, co-authoring the discovery of SUMO/Sentrin, and the cloning of Class H defect in Glycosylphosphatidylinositol Anchor. Recently she devoted majority of her time on onco-cardiology (cardio-oncology). With her cross-discipline expertise in epidemiology, evidence-based medicine, and basic research, she translated bench laboratory data to bedside clinical trials for prevention of doxorubicin-induced cardiotoxicity. This investigator initiated clinical trials received 3.48 million NIH RO1 award, HL 151993, 6/2020-5/2025.

 

Dr. Chang’s academic background:

 

Faculty appointments:

Department of Pharmacology/Toxicology and Department of Internal Medicine

Professor

Education:

Fellowship

Harvard Medical School, Boston Children’s Hospital

Anesthesiology

Fellowship

Harvard Medical School, Boston Children’s Hospital

Research in Pain Medicine

Residency

Boston University Medical Center

Anesthesiology

Internship

George Washington University Medical Center

Graduate School

Harvard Chan School of Public Health

Master of Science in Physiology

Master of Public Health in Epidemiology

Medical School

National Taiwan University